DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Breakthrough infection
Breakthrough infection
COVID-19 Natural Immunity
Outbreak of SARS-Cov-2 Infections, Including COVID-19 Vaccine
SARS-Cov-2 Vaccine Breakthrough Infections Are Asymptomatic Or Mildly Symptomatic and Are Infrequently Transmitted
Effect of Vaccination and of Prior Infection on Infectiousness of Vaccine Breakthrough Infections and Reinfections
Differences in the Concentration of Anti-SARS-Cov-2 Igg Antibodies Post-COVID-19 Recovery Or Post-Vaccination
2021.07.01.450676V1.Full.Pdf
“Breakthrough” Infection?
Natural History of SARS-Cov-2 Infection
Systematic Review of Available Evidence on Effectiveness and Duration of Protection of Varicella Vaccines
Chapter 22: Varicella; Epidemiology and Prevention of Vaccine
The Importance of MMR Immunization in the United States Olivia Perrone, MD, H
Pre-/Post Licensure Assessments of COVID-19 Vaccine Efficacy Against Infection & Transmission
Comparing SARS-Cov-2 Natural Immunity to Vaccine-Induced Immunity: Reinfections Versus Breakthrough Infections
Interim Public Health Considerations for the Provision of Additional COVID-19 Vaccine Doses 1 September 2021
Executive Summary of Evidence Related to COVID-19 Vaccine
Clinical Characteristics of Hospitalized COVID-19 Patients Who Received at Least One Dose of COVID-19 Vaccine
Case Study of Two Post Vaccination SARS-Cov-2 Infections with P1 Variants in Coronavac Vaccinees in Brazil
SARS-Cov-2 Infections After Vaccination – What We Know So Far
Top View
The Impact of Differential Antiviral Immunity in Children and Adults
Risk of SARS-Cov-2 Transmission from Newly- Infected Individuals with Documented Previous Infection Or Vaccination 29 March 2021
Fatal Breakthrough Infection After Anti-BCMA CAR-T Therapy
Delta Variant: What We Know About the Science | CDC
(ACIP) Data and Clinical Considerations
Real-Time Learning Network Vaccines FAQ Last Reviewed: August 24, 2021
Results of COVID-19 Vaccine Effectiveness Studies: an Ongoing Systematic Review
Infection Prevention and Control During Health Care When Coronavirus Disease (COVID-19) Is Suspected Or Confirmed Interim Guidance 12 July 2021
US Influenza Vaccine Effectiveness Network Protocol for Influenza and Other Respiratory Viruses (Including COVID-19)
Poor Antibody Response to Biontech/Pfizer COVID-19 Vaccination
“Breakthrough” Infection?
Coronavirus Disease 2019 (COVID-19) Frequently Asked Questions